Assessment of safety and efficacy of ferric carboxymaltose (Ferinject ®) in the management of iron deficiency with anaemia (IDA) or without anaemia in children and adolescents with inflammatory bowel disease (IBD)

被引：0
|
作者：
Hachemi, S. [1 ]
Mutalib, M. [1 ]
Chadokufa, S. [1 ]
Huggett, B. [1 ]
Sider, S. [1 ]
Shah, N. [1 ]
Whitley, L. [2 ]
McCartney, S. [2 ]
Kiparissi, F. [1 ,2 ]
机构：
[1] Great Ormond St Hosp Sick Children, Paediat Gastroenterol, London WC1N 3JH, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P377
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [1] Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
    Aysegül Aksan
    Fred Zepp
    Sangeetha Anand
    Jürgen Stein
    European Journal of Pediatrics, 2022, 181 : 3781 - 3793
  • [2] Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
    Aksan, Ayseguel
    Zepp, Fred
    Anand, Sangeetha
    Stein, Juergen
    EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (11) : 3781 - 3793
  • [3] Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice
    Stein, Juergen
    Aksan, Ayseguel
    Klemm, Wolfgang
    Nip, Kerry
    Weber-Mangal, Susanne
    Dignass, Axel
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (07): : 826 - 834
  • [4] Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia
    Maria Huguet, Jose
    Cortes, Xavier
    Maia Bosca-Watts, Marta
    Munoz, Margarita
    Maroto, Nuria
    Iborra, Marisa
    Hinojosa, Esther
    Capilla, Maria
    Asencio, Carmina
    Amoros, Cirilo
    Maria Paredes, Jose
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [5] Safety and efficacy of ferric carboxymaltose (FCM) for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD)
    Cococcioni, L.
    Elzein, A.
    Sider, S.
    Chadokufa, S.
    Buckingham, R.
    Ocholi, A.
    Shah, N.
    McCartney, S.
    Saliakellis, E.
    Borrelli, O.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S337 - S337
  • [6] Intravenous ferric carboxymaltose is effective and safe for the treatment of iron deficiency anaemia in children affected by inflammatory bowel disease
    Knafelz, D.
    Acton, N.
    Angelakopoulou, A.
    Sider, S.
    Chadokufa, S.
    Shah, N.
    Kiparissi, F.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (04) : E261 - E261
  • [7] Anaemia and iron deficiency in children with Inflammatory Bowel Disease
    Fleming, B. J.
    Wiskin, A. E.
    Wootton, S. A.
    Beattie, R. M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2011, 70 (OCE5) : E287 - E287
  • [8] Anaemia and iron deficiency in children with inflammatory bowel disease
    Wiskin, Anthony E.
    Fleming, Ben J.
    Wootton, Stephen A.
    Beattie, R. Mark
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (06): : 687 - 691
  • [9] Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease
    Jimenez, Kristine Michelle
    Gasche, Christoph
    ACTA HAEMATOLOGICA, 2019, 142 (01) : 30 - 36
  • [10] Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial
    Zoller, Heinz
    Wolf, Myles
    Blumenstein, Irina
    Primas, Christian
    Lindgren, Stefan
    Thomsen, Lars L.
    Reinisch, Walter
    Iqbal, Tariq
    GUT, 2023, 72 (04) : 644 - 653
12345